Tag: cdna orf

August 27, 2020

Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Efficacy of Rituximab and Plasma Trade in Antineutrophil Cytoplasmic Antibody-Related Vasculitis with Extreme Renal Illness Background: Therapy of sufferers with ANCA-associated vasculitis (AAV) and extreme renal involvement just isn’t established. We describe outcomes in response to rituximab (RTX) versus cyclophosphamide (CYC) and plasma trade (PLEX). Strategies: A retrospective cohort examine of MPO- or PR3-ANCA-positive sufferers with AAV (MPA and GPA) and extreme renal illness (eGFR <30 ml/min […]